Full Length Research Paper
References
|
Alam AN, Sarvari J, Motamedifar M, Khoshkharam H, Yousefi M, Moniri R, Bazargani A (2018). The occurrence of blaTEM, blaSHV and blaOXA genotypes in Extended-Spectrum β-Lactamase (ESBL)-producing Pseudomonas aeruginosa strains in Southwest of Iran. Gene Reports 13:19-23. |
|
|
Allegranzi B, Pittet D (2007). Health care-associated infection in developing countries: simple solutions to meet complex challenges. Infection Control and Hospital Epidemiology 28(12):1323-1327. |
|
|
Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022 Feb12; 399 (10325):629-655. Epub 2022 Jan 19. Erratum in: Lancet 400(10358):1102. PMID: 35065702; PMCID: PMC8841637. |
|
|
Babini GS, Yuan M, Hall LM, Livermore DM (2003). Variable susceptibility to piperacillin / tazo-bactam amongst Klebsiella spp. with extended-spectrum b- lactamases. Journal of Antimicrobial Chemotherapy 51(3):605-612. |
|
|
Borg MA, Cookson BD, Zarb P, Scicluna EA (2009). Antibiotic resistance surveillance and control in the Mediterranean region: report of the ARMed consensus conference. The Journal of Infection in Developing Countries 3(9):654-659. |
|
|
Carle S (2009). Antibiotic resistance: an important public health issue. Pharmacteul 42(2):16. |
|
|
Daniau C, Léon L, Blanchard H, Bernet C, Caillat-Vallet E, Glorion S, Buonocore l, Aupée M, Péfau M, Simon L, Claver J (2017). Infections associated with care in health establishments: Results of the 2017 National Prevalence Survey. |
|
|
Daniau C, Léon L, Blanchard H, Bernet C, Caillet-Vallet E, Glorion S, Buoconore L, Aupée M, Péfau M, Simon L, Claver J, Bajolet O, Alfandari S, Berger-Carbonne A, Coignard B (2018). Enquête nationale de prévalence des infections nosocomiales et des traitements anti- infectieux en établissements de santé, France, mai-juin 2017. Saint-Maurice : Santé Publique France P 12. |
|
|
David M, Day M, Cleary P, Katie L, Hopkins, Mark A, Toleman WD, Wareham CW, Michel D, Neil W (2019). OXA-1 β-lactamase and non- susceptibility to penicillin / β-lactamase inhibitor combination among ESBL- producing Escherichia coli. Journal of Antimicrobial Chemotherapy 74(2):326-333. |
|
|
Déguénonvo LF, Traoré K, Dia NM, Ka R, Cissoko Y, Diouf A, Lakhe NA, ka D, Diop SA, Cisse VMP, Manga MN, Ndour CT, Soumaré M, Sow AI, Seydi M (2015). Results of a survey incidence of the cases of nosocomial infections with multidrug resistant bacteria in a hospital center in Dakar (Senegal) Revue Malienne d'Infectiologie et de Microbiologie 2015, Tome 5. |
|
|
Diagbouga S, Salah FD, Sadji AY, Dabire MA, Nadembega C, Kere AB, Soubeiga ST, Ouattara AK, Zohoncon T, Belemgnegre M, Karou S, Simpore J (2016). Detection of high prevalence of TEM/SHV/CTX-M genes in ESBL producing and multidrug resistant Klebsiella Pneumonia and Klebsiella Oxytoca. Journal of Clinical and Diagnostic Research 4(1):130. |
|
|
EUCAST-CASFM (2021). Comité de l'Antibiogramme de la Société Française de Microbiologie Recommandations 2021 V.1.0 Avril. |
|
|
Ghaima KK (2018). Distribution of extended spectrum beta-lactamase (ESBL) genes among Acinetobacter baumannii isolated from burn infections. MOJ Cell Science and Report 5(3):42-46. |
|
|
Karmele C, Javier P, Rodrigo A (2003). Simple and reliable multiplex PCR assay for detection of blaTEM, blaSHV and blaOXA-1 genes in enterobactericeae. FEMS Microbiology Letters 223(2):147-151. |
|
|
Manyahi J, Moyo SJ, Tellevik MG, Ndugulile F, Urassa W, Blomberg B, Langeland N (2017). Detection of CTX-M-15 beta-lactamases in Enterobacteriaceae causing hospital- and community-acquired urinary tract infections as early as. 2004, in Dar es Salaam, Tanzania. BMC Infectious Diseases 17:1-7. |
|
|
Olonitola OS, Olayinka AT, Inabo IH, Shaibu AM (2007). Production of extended spectrum beta-lactamases of urinary isolates of Escherichia coli and Klebsiella pneumoniae in Ahmadu Bello University Teaching Hospital, Zaria, Nigeria. International Journal of Biological and Chemical Sciences 1(2):181-185. |
|
|
Pittet D, Allegranzi, B, Storr J, Nejad SB, Dziekan, G, Leotsakos A, Donaldson L (2008). Infection control as a major World Health Organization priority for developing countries. Journal of Hospital Infections 68(4):285-292. |
|
|
Rawat D, Nair D (2010). Extended-spectrum β -lactamases in Gram Negative Bacteria. Journal of Global Infectious Diseases 2(3):263-274. |
|
|
Salah FD, Diagbouga S, Dabire MA, Sadji AY, Nadembega C, Moumouni A, Soubeiga ST, Ouattara AK, Zohoncon T, Kere AB, Karou S, Simpore J (2017). First detection of Resistance genes encoding extended Spectrum β-lactamase producing Escherichia coli at Lomé, Togo. Archives of Clinical Microbiology 7(6):32. |
|
|
Santé Publique France (2019). "Surveillance des bactéries multirésistantes dans les établissements de santé. Réseau BMR-Raisin, France. Résultats 2017. Santé Publique France, pp. 1-94. |
|
|
Serretiello E, Folliero V, Santella B, Giordano G, Santoro E, De Caro F, Pagliano P, Ferro M, Aliberti SM, Capunzo M, Galdiero M (2021). Trend of Bacterial Uropathogens and Their Susceptibility Pattern: Study of Single Academic High - Volume Center in Italy (2015-2019). International Journal of Microbiology pp. 1-10. |
|
|
Silva J, Aguilar C, Ayala G, Estrada MA, Garza-Ramos.U, Lara-Lemus R, Ledezma L (2000). TLA- 1: a new plasmid-mediated extended-spectrum β-lactamase from Escherichia coli. Antimicrobial Agents and Chemotherapy 44:997-1003. |
|
|
Sugumar M, Kumar KM, Manoharan A, Anbarasu A, Ramaiah S (2014). Detection of OXA-1 b- lacta -mase gene of Klebsiella pneumoniae from bloodstream infections (BSI) by conventional PCR and in-silico analysis to understand the mechanism of OXA mediated resistance. PLoS One 9(3):e91800. |
|
|
Trang NH, Nga TV, Campbell JI, Hiep NT, Farrar J, Baker S, Duy PT (2023). The characterization of ESBL genes in Escherichia coli and Klebsiella pneumoniae causing nosocomial infections in Vietnam. Journal of Infection in Developing Countries 7(12):922-928. |
|
|
Trze?niewska-Ofiara Z, Mendrycka M, Cudo A, Szmulik M, Wo?niak-Kosek A (2022). Hospital Urinary Tract Infections in Healthcare Units on the Example of Mazovian Specialist Hospital Ltd ORIGINAL RESEARCH article Frontiers in Cellular and Infection Microbiology 12:891796. |
|
|
WHO (2017). Press release GENEVA WHO of February 27, 2017. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
